Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 2118 | 4652 | 31.9 | 70% |
Classes in level above (level 3) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 499 | 19953 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
Classes in level below (level 1) |
| ID, lev. below | Publications | Label for level below |
|---|---|---|
| 4661 | 1675 | CHEMOSENSITIVITY TEST//HISTOCULTURE DRUG RESPONSE ASSAY//CD DST |
| 8445 | 1183 | HUMANIZED MICE//HU PBL SCID//SCID MOUSE |
| 12114 | 867 | SURGICAL ORTHOTOPIC IMPLANTATION//ORTHOTOPIC IMPLANTATION//ORTHOTOPIC MOUSE MODELS |
| 20072 | 413 | FP3//HOLLOW FIBRE ASSAY//AFFILIATED ZHUJI HOSP |
| 24532 | 259 | BINUCLEATED LYMPHOCYTES//POLYCLONAL LYMPHOCYTOSIS//PPBL |
| 29808 | 146 | BUCCAL DRUG ABSORPTION//HUMAN ENDOMETRIAL ADENOCARCINOMA//BIOL CHEM ERNAHRUNGSWISSEN AFT |
| 32344 | 109 | TRANSPLACENTAL MUTAGENICITY//ANTITUMOR PREPARATIONS//CANA3DTPA |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BINUCLEATED LYMPHOCYTES | Author keyword | 45 | 94% | 0% | 16 |
| 2 | HUMANIZED MICE | Author keyword | 38 | 46% | 1% | 62 |
| 3 | CHEMOSENSITIVITY TEST | Author keyword | 33 | 57% | 1% | 39 |
| 4 | HU PBL SCID | Author keyword | 22 | 81% | 0% | 13 |
| 5 | POLYCLONAL LYMPHOCYTOSIS | Author keyword | 21 | 85% | 0% | 11 |
| 6 | SURGICAL ORTHOTOPIC IMPLANTATION | Author keyword | 21 | 85% | 0% | 11 |
| 7 | SCID MOUSE | Author keyword | 18 | 25% | 1% | 61 |
| 8 | SCID MICE | Author keyword | 17 | 19% | 2% | 81 |
| 9 | ORTHOTOPIC IMPLANTATION | Author keyword | 16 | 44% | 1% | 28 |
| 10 | HISTOCULTURE DRUG RESPONSE ASSAY | Author keyword | 16 | 58% | 0% | 18 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | BINUCLEATED LYMPHOCYTES | 45 | 94% | 0% | 16 | Search BINUCLEATED+LYMPHOCYTES | Search BINUCLEATED+LYMPHOCYTES |
| 2 | HUMANIZED MICE | 38 | 46% | 1% | 62 | Search HUMANIZED+MICE | Search HUMANIZED+MICE |
| 3 | CHEMOSENSITIVITY TEST | 33 | 57% | 1% | 39 | Search CHEMOSENSITIVITY+TEST | Search CHEMOSENSITIVITY+TEST |
| 4 | HU PBL SCID | 22 | 81% | 0% | 13 | Search HU+PBL+SCID | Search HU+PBL+SCID |
| 5 | POLYCLONAL LYMPHOCYTOSIS | 21 | 85% | 0% | 11 | Search POLYCLONAL+LYMPHOCYTOSIS | Search POLYCLONAL+LYMPHOCYTOSIS |
| 6 | SURGICAL ORTHOTOPIC IMPLANTATION | 21 | 85% | 0% | 11 | Search SURGICAL+ORTHOTOPIC+IMPLANTATION | Search SURGICAL+ORTHOTOPIC+IMPLANTATION |
| 7 | SCID MOUSE | 18 | 25% | 1% | 61 | Search SCID+MOUSE | Search SCID+MOUSE |
| 8 | SCID MICE | 17 | 19% | 2% | 81 | Search SCID+MICE | Search SCID+MICE |
| 9 | ORTHOTOPIC IMPLANTATION | 16 | 44% | 1% | 28 | Search ORTHOTOPIC+IMPLANTATION | Search ORTHOTOPIC+IMPLANTATION |
| 10 | HISTOCULTURE DRUG RESPONSE ASSAY | 16 | 58% | 0% | 18 | Search HISTOCULTURE+DRUG+RESPONSE+ASSAY | Search HISTOCULTURE+DRUG+RESPONSE+ASSAY |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | HU MOUSE | 115 | 77% | 2% | 78 |
| 2 | HUMAN IMMUNE SYSTEM | 73 | 53% | 2% | 96 |
| 3 | SCID IL2R GAMMANULL MICE | 70 | 78% | 1% | 46 |
| 4 | INVITRO CHEMOSENSITIVITY | 46 | 65% | 1% | 44 |
| 5 | 3 DIMENSIONAL HISTOCULTURE | 36 | 83% | 0% | 20 |
| 6 | HISTOLOGICALLY INTACT TISSUE | 35 | 89% | 0% | 16 |
| 7 | RAG2 GAMMA C MICE | 33 | 83% | 0% | 19 |
| 8 | MTT ASSAY | 28 | 28% | 2% | 86 |
| 9 | SCID HU MOUSE | 25 | 23% | 2% | 95 |
| 10 | COLONY FORMING ASSAY | 24 | 68% | 0% | 21 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Humanized mice for immune system investigation: progress, promise and challenges | 2012 | 112 | 123 | 65% |
| Patient-derived tumour xenografts as models for oncology drug development | 2012 | 142 | 106 | 42% |
| Current advances in humanized mouse models | 2012 | 50 | 79 | 72% |
| Humanized mice in translational biomedical research | 2007 | 460 | 125 | 35% |
| Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic | 1999 | 273 | 105 | 51% |
| The multiple uses of fluorescent proteins to visualize cancer in vivo | 2005 | 348 | 73 | 48% |
| One mouse, one patient paradigm: New avatars of personalized cancer therapy | 2014 | 24 | 75 | 33% |
| New generation humanized mice for virus research: Comparative aspects and future prospects | 2013 | 36 | 147 | 51% |
| Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research | 2014 | 18 | 70 | 40% |
| Human Hemato-Lymphoid System Mice: Current Use and Future Potential for Medicine | 2013 | 41 | 198 | 41% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | AFFILIATED ZHUJI HOSP | 3 | 43% | 0.1% | 6 |
| 2 | CHEMOSENSITIVITATESTUNGEN | 3 | 100% | 0.1% | 3 |
| 3 | HEMATOL IMMUNOL CLIN | 3 | 100% | 0.1% | 3 |
| 4 | ZHEJIANG CANC HOSP | 3 | 45% | 0.1% | 5 |
| 5 | ANTICANCER INC | 2 | 67% | 0.0% | 2 |
| 6 | GI HEPATOBILIARY GRP | 2 | 67% | 0.0% | 2 |
| 7 | GRP CELLULAR MACHINES | 2 | 67% | 0.0% | 2 |
| 8 | VIRUS PATHOGENESIS | 2 | 67% | 0.0% | 2 |
| 9 | MICHAEL DARMADY | 2 | 40% | 0.1% | 4 |
| 10 | BILL MELINDA GATES FDN GRAND CHALLENGES GLOBAL | 1 | 100% | 0.0% | 2 |
Related classes at same level (level 2) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000011384 | LAMININ//FIBRONECTIN//INVASION & METASTASIS |
| 2 | 0.0000009315 | ONCOLYTIC VIRUS//VIROTHERAPY//CYTOSINE DEAMINASE |
| 3 | 0.0000007367 | LY573636//TASISULAM//CHEM TECHNOL DRUGS |
| 4 | 0.0000007027 | BNCT//BORON NEUTRON CAPTURE THERAPY//TIRAPAZAMINE |
| 5 | 0.0000006882 | INTRAPERITONEAL CHEMOTHERAPY//CYTOREDUCTIVE SURGERY//PERITONEAL CARCINOMATOSIS |
| 6 | 0.0000006403 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//ABCG2 |
| 7 | 0.0000006401 | TUMOR DORMANCY//DORN VA MED//CONCOMITANT RESISTANCE |
| 8 | 0.0000006398 | ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY//CYTOMETRY//IMAGE CYTOMETRY |
| 9 | 0.0000006361 | DIHYDROPYRIMIDINE DEHYDROGENASE//5 FLUOROURACIL//THYMIDINE PHOSPHORYLASE |
| 10 | 0.0000005918 | TIP30//LYMPHATIC SYSTEM MR//LYMPHOGRAPHY |